R43GM150314
Project Grant
Overview
Grant Description
Next generation free energy perturbation (FEP) calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromises.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Massachusetts
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have decreased 50% from $297,864 to $148,932.
Quantum Simulation Technologies was awarded
Project Grant R43GM150314
worth $148,932
from the National Institute of General Medical Sciences in April 2023 with work to be completed primarily in Massachusetts United States.
The grant
has a duration of 5 months and
was awarded through assistance program 93.859 Biomedical Research and Research Training.
The Project Grant was awarded through grant opportunity PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed).
SBIR Details
Research Type
SBIR Phase I
Title
Next generation free energy perturbation (FEP)calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromises
Abstract
Project Summary The value of computational chemistry to commercial drug discovery is now well-established. Virtual screening (including molecular docking) now jumpstarts most discovery efforts. More recently, a combination of GPU and cloud based computing has vastly increased the realistic computational throughput available for drug discovery. In turn, this has ignited substantial interest in relative free energy calculations (e.g. Free Energy Perturbation, FEP) for drug lead enhancement. FEP has been applied at the fringes of drug discovery for decades, but massive parallelism in the more recent past has moved FEP to center stage, and FEP has helped shave months or years off discovery efforts where these calculations are reliable. The catch is that FEP calculations are not always reliable. While for some systems, the error in a FEP result is much less than one kcal/mol--and they have successfully steered slow/expensive bench efforts--there are other systems where the predictions are not very useful. Even where retrospective analysis is possible, it is often not very clear why FEP calculations are so good for some target systems, and so bad for others. Broadly, the limitations of FEP can be distilled down to three problems: A poor description of the energetics (force field); insufficient sampling; or a misunderstanding of the fundamental science (e.g., incorrect protein model, wrong binding site, wrong protonation state, etc.). It is generally believed that many issues arise from the first of these—and improving the evaluation of energetics using quantum mechanics (QM) will be the focus here. There is a huge interest in methods that can help obviate the existing problems with FEP. Herein, we propose a new platform for FEP, which incorporates a quantum mechanical description of the molecular interaction of central interest. The traditional force field used with FEP is a simplified analytic expression with fit coefficients termed Molecular Mechanics (MM). MM is a simple approximation of the true molecular interactions that can be described using quantum mechanics. But QM has been, until recently, far too expensive to use in the context of the molecular dynamics (MD) sampling required for FEP. At long last, we have determined how to integrate QM into the FEP paradigm, using a carefully programmed distributed processing platform that lends itself to use on commodity cloud computers, and by integrating a semiempirical QM implementation that provides predictions that are much better than those from MM, but at a cost far less than for a full DFT QM prediction. Our implementation allows FEP calculations with a realistic QM core region of hundreds of atoms to be carried out with the scale of sampling associated with accurate FEP calculations and with turnaround commensurate with modern drug discovery. Here, we propose to validate this platform against traditional MM-based FEP, to show it addresses many of the issues of that approach. We will also identify additional implementation ideas to further improve effective throughput and/or accuracy.
Topic Code
400
Solicitation Number
PA22-176
Status
(Complete)
Last Modified 3/5/24
Period of Performance
4/1/23
Start Date
9/30/23
End Date
Funding Split
$148.9K
Federal Obligation
$0.0
Non-Federal Obligation
$148.9K
Total Obligated
Activity Timeline
Transaction History
Modifications to R43GM150314
Additional Detail
Award ID FAIN
R43GM150314
SAI Number
R43GM150314-807383869
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Small Business
Awarding Office
75NS00 NIH NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
Funding Office
75NS00 NIH NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
Awardee UEI
XH9CRG6SG987
Awardee CAGE
8EJG6
Performance District
MA-90
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) | Health research and training | Grants, subsidies, and contributions (41.0) | $148,932 | 100% |
Modified: 3/5/24